These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 27588488)

  • 21. MiR-27a modulates radiosensitivity of triple-negative breast cancer (TNBC) cells by targeting CDC27.
    Ren YQ; Fu F; Han J
    Med Sci Monit; 2015 May; 21():1297-303. PubMed ID: 25943633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1.
    Lin LC; Lee HT; Chien PJ; Huang YH; Chang MY; Lee YC; Chang WW
    Int J Med Sci; 2020; 17(14):2214-2224. PubMed ID: 32922184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of ionizing radiation response by histamine in vitro and in vivo in human breast cancer.
    Martinel Lamas DJ; Cortina JE; Ventura C; Sterle HA; Valli E; Balestrasse KB; Blanco H; Cremaschi GA; Rivera ES; Medina VA
    Cancer Biol Ther; 2015; 16(1):137-48. PubMed ID: 25482934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth.
    Huang YH; Peng W; Furuuchi N; Gerhart J; Rhodes K; Mukherjee N; Jimbo M; Gonye GE; Brody JR; Getts RC; Sawicki JA
    Cancer Res; 2016 Mar; 76(6):1549-59. PubMed ID: 26921342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells.
    Jimbo M; Blanco FF; Huang YH; Telonis AG; Screnci BA; Cosma GL; Alexeev V; Gonye GE; Yeo CJ; Sawicki JA; Winter JM; Brody JR
    Oncotarget; 2015 Sep; 6(29):27312-31. PubMed ID: 26314962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posttranscriptional Regulation of
    Chand SN; Zarei M; Schiewer MJ; Kamath AR; Romeo C; Lal S; Cozzitorto JA; Nevler A; Scolaro L; Londin E; Jiang W; Meisner-Kober N; Pishvaian MJ; Knudsen KE; Yeo CJ; Pascal JM; Winter JM; Brody JR
    Cancer Res; 2017 Sep; 77(18):5011-5025. PubMed ID: 28687616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapy.
    Wei L; Zhang Q; Zhong C; He L; Zhang Y; Armaly AM; Aubé J; Welch DR; Xu L; Wu X
    Mol Oncol; 2023 Oct; 17(10):1962-1980. PubMed ID: 37357618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myricetin-induced apoptosis of triple-negative breast cancer cells is mediated by the iron-dependent generation of reactive oxygen species from hydrogen peroxide.
    Knickle A; Fernando W; Greenshields AL; Rupasinghe HPV; Hoskin DW
    Food Chem Toxicol; 2018 Aug; 118():154-167. PubMed ID: 29742465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer.
    Zhang Z; Lu M; Chen C; Tong X; Li Y; Yang K; Lv H; Xu J; Qin L
    Theranostics; 2021; 11(7):3167-3182. PubMed ID: 33537080
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytotoxicity of new pyridazin-3(2H)-one derivatives orchestrating oxidative stress in human triple-negative breast cancer (MDA-MB-468).
    Bouchmaa N; Ben Mrid R; Boukharsa Y; Nhiri M; Ait Mouse H; Taoufik J; Ansar M; Zyad A
    Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800128. PubMed ID: 30370633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells).
    Meena R; Kumar S; Kumar R; Gaharwar US; Rajamani P
    Biomed Pharmacother; 2017 Oct; 94():944-954. PubMed ID: 28810532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
    Kala R; Shah HN; Martin SL; Tollefsbol TO
    BMC Cancer; 2015 Oct; 15():672. PubMed ID: 26459286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity.
    Jayakumar S; Kunwar A; Sandur SK; Pandey BN; Chaubey RC
    Biochim Biophys Acta; 2014 Jan; 1840(1):485-94. PubMed ID: 24121106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin sensitizes carboplatin treatment in triple negative breast cancer through reactive oxygen species induced DNA repair pathway.
    Wang G; Duan P; Wei Z; Liu F
    Mol Biol Rep; 2022 Apr; 49(4):3259-3270. PubMed ID: 35076853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration.
    Muralidharan R; Babu A; Amreddy N; Basalingappa K; Mehta M; Chen A; Zhao YD; Kompella UB; Munshi A; Ramesh R
    J Nanobiotechnology; 2016 Jun; 14(1):47. PubMed ID: 27328938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of metformin action in MCF-7 and MDA-MB-231 human breast cancer cells involves oxidative stress generation, DNA damage, and transforming growth factor β1 induction.
    Marinello PC; da Silva TN; Panis C; Neves AF; Machado KL; Borges FH; Guarnier FA; Bernardes SS; de-Freitas-Junior JC; Morgado-Díaz JA; Luiz RC; Cecchini R; Cecchini AL
    Tumour Biol; 2016 Apr; 37(4):5337-46. PubMed ID: 26561471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deciphering the molecular mechanism underlying anticancer activity of coumestrol in triple-negative breast cancer cells.
    Zafar A; Singh S; Satija YK; Saluja D; Naseem I
    Toxicol In Vitro; 2018 Feb; 46():19-28. PubMed ID: 28986287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.